MRC Human Genetics Unit and the Institute for Genetics and Molecular Medicine, Edinburgh EH4 2XU, UK.
Mol Cell. 2010 Jan 29;37(2):153-5. doi: 10.1016/j.molcel.2010.01.010.
Here, Hartkamp et al. (2010) identify WT1 as a novel bona fide substrate of the HtrA2/Omi mitochondrial protease and show that this reaction modulates WT1 antiapoptotic activity under cytotoxic stress. This supports an oncogenic function for WT1, with implications for novel chemotherapeutic avenues.
在这里,Hartkamp 等人(2010 年)鉴定 WT1 是 HtrA2/Omi 线粒体蛋白酶的一种新的真正底物,并表明该反应在细胞毒性应激下调节 WT1 的抗凋亡活性。这支持了 WT1 的致癌功能,为新的化疗途径提供了启示。